Mr Mrs Miss Ms Dr Other

Miss
Ruby
Mullens

Trainee Patent Attorney

London Office

Life sciences

Telephone. +44(0) 161 247 4900
Email. rmullens@hgf.com
Vcard
Linkedin

Experience

Ruby graduated in 2023 with a first class Master's degree in Biochemistry from the University of Oxford, where she was awarded scholarships and academic prizes in recognition of her performance. She since joined HGF in January 2025 as a Trainee Patent Attorney in the Life Science team.

She has a broad technical background, having studied genetics, molecular & cellular biology, metabolic processes, macromolecular structures, drug design, chemical pharmacology, bacterial warfare, antibiotic resistance, and biochemical methods.

During her Master's, Ruby conducted a research project in Neurobiology at the Szele Lab, University of Oxford. Here she explored the role of tumour-associated lncRNAs in neural migration using a range of in-vitro and in-vivo gene editing techniques. In the same year, she completed a comprehensive review of β2-adrenoreceptor signaling in skeletal muscle, offering insights into its therapeutic potential for glucometabolic regulation in type 2 diabetes.

Ruby's particular interests and expertise lie in human metabolism, cellular signaling, cancer biology, and disease pathogenesis at the molecular and cellular level.

Specialisms

Industries

Services

Qualifications

Trainee

MBIOCHEM

MBiochem in Molecular and Cellular Biochemistry, University of Oxford (First Class Honours)

OTHER

Supplemental Subject in Chemical Pharmacology (Distinction)

Recognition

Nuffield Scholarship in Biochemistry, St Hilda's College, University of Oxford

View recognition online

Download recognition PDF

Porter Prize for Performance, Department of Biochemistry, University of Oxford

View recognition online

Download recognition PDF

Proxime Accessit Gibbs Prize for Performance, Department of Biochemistry, University of Oxford

View recognition online

Download recognition PDF

Related News

Office Closed Dates December 2025 / January 2026

HGF Office Closed Dates December 2025 / January 2026   UK Thursday 25 and Friday 26 December 2025 CLOSED Thursday 1 January 2026* CLOSED * Friday 2 January 2026 – …

Read article

PRESS RELEASE – HGF strengthens European presence with three new Partners in France and Germany

HGF is pleased to announce the arrival of three new partners, further strengthening its European presence. Two partners will be joining the firm’s fast-growing French practice, and one will join …

Read article

G1/23: The Enlarged Board of Appeal shift EPO practice towards an “on-sale” bar.

Last week, the EPO’s Enlarged Board of Appeal (EBA) issued its Decision that both a product put on the market before the date of filing of a European patent application, …

Read article

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

Empowered, Not Replaced: The Risks and Rewards of Using AI Tools in Patent Prosecution

With the rapid rise of AI and extreme hype around generative AI tools in the workplace, patent firms around the world have had to seriously consider to what extent they …

Read article

EU Agrees on NGT Plant Regulation: What It Means for Patents and Licensing

The European Parliament and Council have reached a provisional agreement for plants developed using New Genomic Techniques (NGTs) – below we summarise the main points and set out the requirements …

Read article

When Retail Branding Meets Politics

(Inter IKEA Systems v Algemeen Vlaams Belang (Case C‑298/23) In November 2022, the Flemish political party Vlaams Belang presented its “IKEA-PLAN – Immigratie Kan Echt Anders” (“Immigration Really Can Be Different”). …

Read article
See all updates

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.

Contact us